Delon Canterbury
Chief Executive Officer, GeriatRx
Professional Overview
Delon Canterbury is an accomplished healthcare leader with extensive experience in the pharmaceutical industry. As the Chief Executive Officer of GeriatRx, he leverages his expertise in pharmacy operations, specialty care, and geriatric medicine to drive innovation and improve patient outcomes.
Experience Summary
Current Role
As the Chief Executive Officer of GeriatRx since 2019, Delon is responsible for overseeing the strategic direction, operational efficiency, and financial performance of the company. Under his leadership, GeriatRx has expanded its specialty pharmacy services and developed targeted programs to address the unique healthcare needs of the geriatric population. Delon's focus on patient-centered care and evidence-based practices has positioned GeriatRx as a leading provider of comprehensive pharmaceutical solutions for elderly patients.
Career Progression
Prior to his current role, Delon held various positions at Walgreens, including Pharmacist, Local Specialty Pharmacy Manager, and Pharmacy Supervisor. He gained valuable experience in pharmacy operations, medication management, and team leadership. Delon also has a background in academic research, having served as an Antibiotic Research Assistant at the UNC Eshelman School of Pharmacy and a Research Assistant at the Lineberger Cancer Institute.
Academic Background
Delon holds a Doctor of Pharmacy (PharmD) degree from the UNC Eshelman School of Pharmacy, where he graduated with distinction and demonstrated a strong commitment to research and innovation.
Areas of Expertise
- Pharmacy operations and management
- Specialty pharmacy services
- Geriatric medicine and medication management
- Strategic planning and business development
- Driving operational excellence and financial performance
- Fostering a culture of patient-centered care and continuous improvement
Professional Impact
Under Delon's leadership, GeriatRx has expanded its reach and impact within the geriatric healthcare sector. He has spearheaded the development of novel programs and partnerships that have improved medication adherence, reduced hospital readmissions, and enhanced the overall quality of life for elderly patients. Delon's dedication to addressing the unique needs of the geriatric population has earned him recognition as a thought leader in the industry.
Conclusion
Delon Canterbury's extensive experience, proven leadership, and commitment to innovation make him a valuable asset to the healthcare industry. As the Chief Executive Officer of GeriatRx, he continues to drive positive change, optimize patient outcomes, and position the company as a leader in the field of geriatric pharmacy services.
